All apps & connectors
Openlandscape logo

Openlandscape

ClaudeCommunityby Feynman OÜ

OpenLandscape tracks the drugs in clinical development, built from ClinicalTrials.gov, openFDA and company filings. Each drug's names are merged across codes and brands (mazdutide = LY3305677 = IBI362), so one question finds it under any name. Ask in plain words: - "Map every amylin drug in Phase 2 or later, with next milestones." - "Tell me everything about mazdutide." - "Which oral GLP-1s read out in the next six months?" - "List Phase 3 obesity trials running in China." - "Who runs the most Phase 3 lung cancer trials in China?" - "What changed in what I follow this week?" Every answer is a table in which each phase, date and number links to its source (the trial registry record, the FDA label or the press report), so you can check it before you use it. Facts from press reports are marked "news". The data is updated every weekday. What it can do: landscapes of every drug in a disease, target, mechanism or company; one drug in full (names, company, stage, approvals, upcoming dates, trials); trials by drug, company, phase, country or date; upcoming readouts and regulator decisions; the companies and hospitals running the most trials; and what changed in the landscapes, drugs and companies you follow. All tools only read. Nothing in your account can be changed through Claude. A free OpenLandscape account (email or Google, no card) includes 25 questions a month, the top 10 of each list and one landscape in full. Solo ($49 a month, excl. VAT) opens every list, follows 5 landscapes, drugs or companies, and shows every change.

Details

Health Life SciencesData Analytics
Listed Nov 16, 2026
by Feynman OÜ
MCP endpoint: https://openlandscape.app/mcp · streamable-http

Available tools (8)

catalystschangesdruglandscapesearchtrialswho_runs_trialswhoami